Q&A column - CAP TODAY
Clinical significance of HER2 and EGFR expression in colorectal cancer patients with ovarian metastasis | BMC Clinical Pathology | Full Text
Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancer | BMC Cancer | Full Text
Precision Cancer Medicines for Colon Cancer - CancerConnect
Frontiers | Remarkable Response of EGFR- and HER2-Amplified Metastatic Colon Cancer to Pyrotinib After Failed Multiline Treatments: A Case Report and Literature Review
Comprehensive assessment of HER2 alteration in a colorectal cancer coh | CMAR
Frontiers | Human Epidermal Growth Factor Receptor 2 Overexpression and Amplification in Patients With Colorectal Cancer: A Large-Scale Retrospective Study in Chinese Population
HER2 Biomarker | Colorectal Cancer Alliance
Mechanisms of resistance to anti-epidermal growth factor receptor inhibitors in metastatic colorectal cancer
Dual HER2 Blockade in Patients With HER2-Amplified Metastatic
![HER2 and BRAF mutation in colorectal cancer patients: a retrospective study in Eastern China [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2020/8602/1/fig-5-2x.jpg "HER2 and BRAF mutation in colorectal cancer patients: a retrospective study in Eastern China [PeerJ]")
HER2 and BRAF mutation in colorectal cancer patients: a retrospective study in Eastern China [PeerJ]
HER2 in Colorectal Cancer: The Long and Winding Road From Negative Predictive Factor to Positive Actionable Target | American Society of Clinical Oncology Educational Book
HER2 Biomarker | Colorectal Cancer Alliance
A HER2-targeting antibody-MMAE conjugate RC48 sensitizes immunotherapy in HER2-positive colon cancer by triggering the cGAS-STING pathway | Cell Death & Disease
Fulfilling the potential of HER2-targeting in colorectal cancer: update on detection and management - YouTube
HER2 Biomarker in Colon Cancer | Know Your Biomarker
HER2 Status in Colorectal Cancer: Its Clinical Significance and the Relationship between HER2 Gene Amplification and Expression | PLOS ONE
HER2 G776S mutation promotes oncogenic potential in colorectal cancer cells when accompanied by loss of APC function | Scientific Reports
Assessment of a HER2 scoring system for colorectal cancer: results from a validation study | Modern Pathology
Prevalence, prognosis and predictive status of HER2 amplification in anti-EGFR-resistant metastatic colorectal cancer | SpringerLink
The HER family as therapeutic targets in colorectal cancer - ScienceDirect
HER2 in Colorectal Cancer: The Long and Winding Road From Negative Predictive Factor to Positive Actionable Target | American Society of Clinical Oncology Educational Book
HER2 expression and copy number alterations in colorectal cancer (CRC).... | Download Scientific Diagram
Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study - The Lancet Oncology
Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer - ScienceDirect
